Physician profile
Andrew Kingman
NPI 1306076138
$3,835.89
in general payments reported to CMS, 2019-2025
21 companies · $307 in 2025
The $307 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $414 · 2021: $516 · 2022: $371 · 2023: $739 · 2024: $582 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599 · Travel and Lodging: $29.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,598.74 |
| Travel and Lodging | $29.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $994.04 | 2019-2025 | Xtandi, Padcev, Veozah |
| Procept Biorobotics Corporation | $746.47 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $428.10 | 2019-2025 | Rezum Generator, Bulkamid |
| Abbvie INC. | $398.09 | 2019-2025 | |
| Coloplast Corp | $184.45 | 2021-2024 | Restorelle, Speedicath |
| Cook Medical LLC | $157.52 | 2019-2020 | |
| 180 Medical, INC. | $141.17 | 2020-2025 | Gentlecath |
| Janssen Biotech, INC. | $130.44 | 2019-2022 | |
| Globus Medical, INC. | $112.66 | 2019 | |
| Urogen Pharma, INC. | $89.35 | 2020-2025 | Jelmyto |
| Teleflex LLC | $82.55 | 2021 | |
| Pfizer INC. | $72.75 | 2019-2023 | |
| Axonics, INC. | $69.47 | 2023-2024 | Axonics, Bulkamid |
| Ferring Pharmaceuticals INC. | $62.14 | 2019-2025 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $60.57 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $25.66 | 2019-2022 | |
| Myovant Sciences INC. | $20.38 | 2021 | |
| Travere Therapeutics, INC. | $16.79 | 2021 | |
| Medtronic USA, INC. | $14.92 | 2020 | |
| Tolmar, INC. | $14.55 | 2023 | |
| Laborie Medical Technologies Corp. | $13.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kingman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.